Four novel cathelicidin antimicrobial peptides isolated from tiger frogs showed broad-spectrum antibacterial activity through membrane disruption and reactive oxygen species induction, and protected fish from bacterial infection in vivo.
4 structurally diverse cathelicidinsA single frog species produces four distinct cathelicidin antimicrobial peptides with different tissue distributions, representing a multi-layered immune defense network
What the researchers found
Four novel cathelicidin genes (cathelicidin-1 through cathelicidin-4) were cloned from tiger frog H. rugulosus, encoding peptides of 153, 188, 132, and 160 amino acids respectively. Sequence comparison revealed highly diverse structures among the four cathelicidins. Each showed distinct tissue-specific expression patterns in healthy frogs, with expression levels changing in tissue- and time-dependent manner when frogs were challenged with A. hydrophila bacteria over 72 hours.
Synthetic cathelicidin-1 and cathelicidin-2 exhibited broad-spectrum in vitro antimicrobial activity through two mechanisms: excessive induction of reactive oxygen species (ROS) and direct disruption of microbial membrane structure. In vivo, intraperitoneal injection of cathelicidin proteins significantly increased marine medaka fish resistance to bacterial challenges, demonstrating cross-species antimicrobial protection.
Why it matters
Amphibian skin peptides are among nature's richest sources of antimicrobial compounds, evolved over hundreds of millions of years. The discovery of four structurally diverse cathelicidins in a single frog species reveals a sophisticated, multi-layered defense system that could inspire new antibiotic development. The dual killing mechanism (membrane disruption + ROS induction) makes bacterial resistance evolution particularly difficult, and the cross-species protective effect in fish demonstrates practical applications in aquaculture.
How the study worked
Full-length cDNA sequences of the four cathelicidins were cloned using RACE (rapid amplification of cDNA ends) technique. Phylogenetic analysis compared their structures to known cathelicidins. Real-time PCR measured tissue distribution in healthy frogs and time-course expression after A. hydrophila bacterial challenge over 72 hours. Synthetic peptides were tested for in vitro antimicrobial activity. Mechanisms were investigated through ROS measurement and membrane integrity assays. In vivo protection was assessed by injecting cathelicidin proteins into marine medaka fish before bacterial challenge.
What this study cannot tell us
The study focused primarily on peptide discovery, characterization, and in vitro/fish in vivo testing. Human therapeutic potential was not directly assessed. The in vivo experiments used fish, not mammalian models. Potential toxicity to host cells was not comprehensively evaluated — an important consideration since ROS-inducing peptides could also damage host tissue. The specific MIC values and spectrum of bacterial targets are not detailed in the abstract. Production scale-up for practical aquaculture use was not addressed.
How to read the evidence
This is a comprehensive peptide discovery and characterization study combining gene cloning, expression analysis, in vitro antimicrobial testing, mechanism of action studies, and in vivo fish protection experiments. The multi-method approach provides strong evidence for the antimicrobial properties of these peptides, though clinical or aquaculture application requires further development.
When this study was published
Published in 2025, this is a very recent study contributing to the growing catalog of amphibian-derived antimicrobial peptides being explored as antibiotic alternatives.
The bigger picture
Cathelicidins are one of the most important antimicrobial peptide families, found across all vertebrates — from frogs to humans (the human cathelicidin LL-37 is a key immune defense peptide). The discovery of four diverse cathelicidins in tiger frogs reflects the evolutionary pressure aquatic and semi-aquatic animals face from waterborne pathogens. These peptides join a growing library of amphibian-derived AMPs being explored as alternatives to conventional antibiotics, particularly for aquaculture where antibiotic resistance is a mounting concern.
Questions still open
- Could these frog cathelicidins serve as templates for designing new antimicrobial drugs for human infections?
- What determines the tissue-specific expression of each cathelicidin, and does this specialization reflect different antimicrobial niches?
- Are these peptides safe for aquaculture use, and do they leave residues in fish meant for human consumption?
Common questions
Why are frogs such a rich source of antimicrobial peptides?
What are cathelicidins and do humans have them too?
Read the original research
Antimicrobial activity and immunomodulation of four novel cathelicidin genes isolated from the tiger frog Hoplobatrachus rugulosus.
Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 289, 110091
Citation
Huang, Danni; Gao, Fulong; Huang, Yixin; Zheng, Ronghui; Fang, Chao; Huang, Wenshu; Wang, Kejian; Bo, Jun. (2025). Antimicrobial activity and immunomodulation of four novel cathelicidin genes isolated from the tiger frog Hoplobatrachus rugulosus.. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP, 289, 110091. https://doi.org/10.1016/j.cbpc.2024.110091